<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Suh J</submitter><funding>Ministry of Trade, Industry and Energy</funding><funding>Ministry of Education</funding><funding>Institute for Basic Science</funding><funding>Korea Drug Development Fund</funding><funding>Korea Health Industry Development Institute</funding><funding>Ministry of Health and Welfare</funding><funding>Ministry of Science, ICT and Future Planning</funding><funding>National Research Foundation of Korea</funding><pagination>101342</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10829737</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>Chondrosarcomas represent the second most common primary bone malignancy. Despite the vulnerability of chondrosarcoma cells to nicotinamide adenine dinucleotide (NAD&lt;sup>+&lt;/sup>) depletion, targeting the NAD&lt;sup>+&lt;/sup> synthesis pathway remains challenging due to broad implications in biological processes. Here, we establish SIRT1 as a central mediator reinforcing the dependency of chondrosarcoma cells on NAD&lt;sup>+&lt;/sup> metabolism via HIF-2α-mediated transcriptional reprogramming. SIRT1 knockdown abolishes aggressive phenotypes of chondrosarcomas in orthotopically transplanted tumors in mice. Chondrosarcoma cells thrive under glucose starvation by accumulating NAD&lt;sup>+&lt;/sup> and subsequently activating the SIRT1-HIF-2α axis. Decoupling this link via SIRT1 inhibition unleashes apoptosis </pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>Decoupling NAD&lt;sup>+&lt;/sup> metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2α axis.</pubmed_title><pmcid>PMC10829737</pmcid><funding_grant_id>IBS-R008-D1</funding_grant_id><funding_grant_id>RS-2023-00213119</funding_grant_id><funding_grant_id>NRF-2020R1A2C2012300</funding_grant_id><funding_grant_id>RS-2023-00217266</funding_grant_id><funding_grant_id>HI21C1218</funding_grant_id><funding_grant_id>NRF-2023R1A2C3003864</funding_grant_id><funding_grant_id>2021RIS-001</funding_grant_id><funding_grant_id>NRF-2020R1C1C1011369</funding_grant_id><funding_grant_id>NRF-2021R1I1A1A01059250</funding_grant_id><pubmed_authors>Min J</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Yeon HJ</pubmed_authors><pubmed_authors>Kang HG</pubmed_authors><pubmed_authors>Kim YJ</pubmed_authors><pubmed_authors>Suh J</pubmed_authors><pubmed_authors>Wu MR</pubmed_authors><pubmed_authors>Hemberg M</pubmed_authors><pubmed_authors>Kim JH</pubmed_authors><pubmed_authors>Scimeca L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Decoupling NAD&lt;sup>+&lt;/sup> metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2α axis.</name><description>Chondrosarcomas represent the second most common primary bone malignancy. Despite the vulnerability of chondrosarcoma cells to nicotinamide adenine dinucleotide (NAD&lt;sup>+&lt;/sup>) depletion, targeting the NAD&lt;sup>+&lt;/sup> synthesis pathway remains challenging due to broad implications in biological processes. Here, we establish SIRT1 as a central mediator reinforcing the dependency of chondrosarcoma cells on NAD&lt;sup>+&lt;/sup> metabolism via HIF-2α-mediated transcriptional reprogramming. SIRT1 knockdown abolishes aggressive phenotypes of chondrosarcomas in orthotopically transplanted tumors in mice. Chondrosarcoma cells thrive under glucose starvation by accumulating NAD&lt;sup>+&lt;/sup> and subsequently activating the SIRT1-HIF-2α axis. Decoupling this link via SIRT1 inhibition unleashes apoptosis </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-07-15T04:38:40.47Z</modification><creation>2024-11-14T14:43:17.479Z</creation></dates><accession>S-EPMC10829737</accession><cross_references><pubmed>38128534</pubmed><doi>10.1016/j.xcrm.2023.101342</doi></cross_references></HashMap>